ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
33 announcements with these filters
Beta Drugs Limited clarified to NSE that recent significant share price movements are purely market-driven. The company confirmed there is no undisclosed price-sensitive information or material announcements pending. Beta Drugs maintains compliance with SEBI transparency regulations and continues to monitor market activity.
Beta Drugs Limited submitted its quarterly compliance certificate for the period ended March 31, 2026. The certificate confirms that security certificates received for dematerialisation were processed and the name of the depositories substituted in the register of members within prescribed timelines. This is a routine regulatory filing with no material financial impact.
Beta Drugs Limited provided a shareholding clarification regarding its proposed preferential issue. Following the issuance of equity shares and conversion of CCDs, the total share capital will increase to 1,10,85,872 shares, with promoter holding adjusting from 64.63% to 59.10%.